A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis

NCT04525352 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Study discontinued due to feasibility.

Conditions

Infantile Malignant Osteopetrosis

Interventions

BIOLOGICAL: RP-L401

Sponsor

Rocket Pharmaceuticals Inc.

Collaborators

[object Object]